One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v126.23.344.344
Copy DOI Journal: Blood |  Publication Date: Dec 3, 2015 |
 Citations: 2 |
Affiliation: University of Adelaide, Hospital São Rafael, Universidade Federal da Bahia, KPJ Ampang Puteri Specialist Hospital, Cairo University, Russian Research Institute of Hematology and Transfusiology, Monash Health, St Vincent's Hospital, Fundación para la Investigación, Docencia y Prevención del Cáncer, University of the Free State, Chang Gung Memorial Hospital, Ministry of Health of the Russian Federation, Tris Pharma (United States), Novartis (India), Princess Margaret Cancer CentreDose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Final Results from ENESTxtnd Study
Sign-in/Register to access full text options 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
